×




Phyto-Riker Pharmaceuticals SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

Case Study SWOT Analysis Solution

Case Study Description of Phyto-Riker Pharmaceuticals


Phyto-Riker, a U.S. investor-led, start-up pharmaceutical company in Ghana, contemplates the effects of needs generated by the HIV epidemic in sub-Saharan Africa on its future business plans. In April 2001, it appeared as if political will was crystallizing around the world for the devotion of substantial resources to fight the epidemic. It was not certain what amount of resources would be available or how the resources would be expended. In the meantime, public health officials, AIDS activists, philanthropists, and pharmaceutical companies were engaged in various activities designed to address the HIV problem from their own points of view.

Authors :: John McMillan, Ade Dosunmu

Topics :: Global Business

Tags :: International business, Strategic planning, SWOT Analysis, SWOT Matrix, TOWS, Weighted SWOT Analysis

Swot Analysis of "Phyto-Riker Pharmaceuticals" written by John McMillan, Ade Dosunmu includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Phyto Riker facing as an external strategic factors. Some of the topics covered in Phyto-Riker Pharmaceuticals case study are - Strategic Management Strategies, International business, Strategic planning and Global Business.


Some of the macro environment factors that can be used to understand the Phyto-Riker Pharmaceuticals casestudy better are - – geopolitical disruptions, supply chains are disrupted by pandemic , wage bills are increasing, central banks are concerned over increasing inflation, increasing government debt because of Covid-19 spendings, increasing household debt because of falling income levels, increasing commodity prices, challanges to central banks by blockchain based private currencies, competitive advantages are harder to sustain because of technology dispersion, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of Phyto-Riker Pharmaceuticals


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Phyto-Riker Pharmaceuticals case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Phyto Riker, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Phyto Riker operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of Phyto-Riker Pharmaceuticals can be done for the following purposes –
1. Strategic planning using facts provided in Phyto-Riker Pharmaceuticals case study
2. Improving business portfolio management of Phyto Riker
3. Assessing feasibility of the new initiative in Global Business field.
4. Making a Global Business topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Phyto Riker




Strengths Phyto-Riker Pharmaceuticals | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of Phyto Riker in Phyto-Riker Pharmaceuticals Harvard Business Review case study are -

Highly skilled collaborators

– Phyto Riker has highly efficient outsourcing and offshoring strategy. It has resulted in greater operational flexibility and bringing down the costs in highly price sensitive segment. Secondly the value chain collaborators of the firm in Phyto-Riker Pharmaceuticals HBR case study have helped the firm to develop new products and bring them quickly to the marketplace.

Strong track record of project management

– Phyto Riker is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

Operational resilience

– The operational resilience strategy in the Phyto-Riker Pharmaceuticals Harvard Business Review case study comprises – understanding the underlying the factors in the industry, building diversified operations across different geographies so that disruption in one part of the world doesn’t impact the overall performance of the firm, and integrating the various business operations and processes through its digital transformation drive.

Cross disciplinary teams

– Horizontal connected teams at the Phyto Riker are driving operational speed, building greater agility, and keeping the organization nimble to compete with new competitors. It helps are organization to ideate new ideas, and execute them swiftly in the marketplace.

Superior customer experience

– The customer experience strategy of Phyto Riker in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.

Sustainable margins compare to other players in Global Business industry

– Phyto-Riker Pharmaceuticals firm has clearly differentiated products in the market place. This has enabled Phyto Riker to fetch slight price premium compare to the competitors in the Global Business industry. The sustainable margins have also helped Phyto Riker to invest into research and development (R&D) and innovation.

High switching costs

– The high switching costs that Phyto Riker has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.

Digital Transformation in Global Business segment

- digital transformation varies from industry to industry. For Phyto Riker digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Phyto Riker has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.

Organizational Resilience of Phyto Riker

– The covid-19 pandemic has put organizational resilience at the centre of everthing that Phyto Riker does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.

Successful track record of launching new products

– Phyto Riker has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Phyto Riker has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.

High brand equity

– Phyto Riker has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Phyto Riker to keep acquiring new customers and building profitable relationship with both the new and loyal customers.

Analytics focus

– Phyto Riker is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by John McMillan, Ade Dosunmu can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.






Weaknesses Phyto-Riker Pharmaceuticals | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of Phyto-Riker Pharmaceuticals are -

No frontier risks strategy

– After analyzing the HBR case study Phyto-Riker Pharmaceuticals, it seems that company is thinking about the frontier risks that can impact Global Business strategy. But it has very little resources allocation to manage the risks emerging from events such as natural disasters, climate change, melting of permafrost, tacking the rise of artificial intelligence, opportunities and threats emerging from commercialization of space etc.

Skills based hiring

– The stress on hiring functional specialists at Phyto Riker has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.

High operating costs

– Compare to the competitors, firm in the HBR case study Phyto-Riker Pharmaceuticals has high operating costs in the. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Phyto Riker 's lucrative customers.

High cash cycle compare to competitors

Phyto Riker has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.

High dependence on existing supply chain

– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Phyto Riker supply chain. Even after few cautionary changes mentioned in the HBR case study - Phyto-Riker Pharmaceuticals, it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Phyto Riker vulnerable to further global disruptions in South East Asia.

Compensation and incentives

– The revenue per employee as mentioned in the HBR case study Phyto-Riker Pharmaceuticals, is just above the industry average. Phyto Riker needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.

Aligning sales with marketing

– It come across in the case study Phyto-Riker Pharmaceuticals that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case Phyto-Riker Pharmaceuticals can leverage the sales team experience to cultivate customer relationships as Phyto Riker is planning to shift buying processes online.

Increasing silos among functional specialists

– The organizational structure of Phyto Riker is dominated by functional specialists. It is not different from other players in the Global Business segment. Phyto Riker needs to de-silo the office environment to harness the true potential of its workforce. Secondly the de-silo will also help Phyto Riker to focus more on services rather than just following the product oriented approach.

Ability to respond to the competition

– As the decision making is very deliberative, highlighted in the case study Phyto-Riker Pharmaceuticals, in the dynamic environment Phyto Riker has struggled to respond to the nimble upstart competition. Phyto Riker has reasonably good record with similar level competitors but it has struggled with new entrants taking away niches of its business.

Capital Spending Reduction

– Even during the low interest decade, Phyto Riker has not been able to do capital spending to the tune of the competition. This has resulted into fewer innovations and company facing stiff competition from both existing competitors and new entrants who are disrupting the industry using digital technology.

Interest costs

– Compare to the competition, Phyto Riker has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.




Opportunities Phyto-Riker Pharmaceuticals | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities highlighted in the Harvard Business Review case study Phyto-Riker Pharmaceuticals are -

Leveraging digital technologies

– Phyto Riker can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Identify volunteer opportunities

– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Phyto Riker can explore opportunities that can attract volunteers and are consistent with its mission and vision.

Lowering marketing communication costs

– 5G expansion will open new opportunities for Phyto Riker in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Global Business segment, and it will provide faster access to the consumers.

Reconfiguring business model

– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Phyto Riker to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.

Redefining models of collaboration and team work

– As explained in the weaknesses section, Phyto Riker is facing challenges because of the dominance of functional experts in the organization. Phyto-Riker Pharmaceuticals case study suggests that firm can utilize new technology to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.

Better consumer reach

– The expansion of the 5G network will help Phyto Riker to increase its market reach. Phyto Riker will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.

Loyalty marketing

– Phyto Riker has focused on building a highly responsive customer relationship management platform. This platform is built on in-house data and driven by analytics and artificial intelligence. The customer analytics can help the organization to fine tune its loyalty marketing efforts, increase the wallet share of the organization, reduce wastage on mainstream advertising spending, build better pricing strategies using personalization, etc.

Changes in consumer behavior post Covid-19

– Consumer behavior has changed in the Global Business industry because of Covid-19 restrictions. Some of this behavior will stay once things get back to normal. Phyto Riker can take advantage of these changes in consumer behavior to build a far more efficient business model. For example consumer regular ordering of products can reduce both last mile delivery costs and market penetration costs. Phyto Riker can further use this consumer data to build better customer loyalty, provide better products and service collection, and improve the value proposition in inflationary times.

Creating value in data economy

– The success of analytics program of Phyto Riker has opened avenues for new revenue streams for the organization in the industry. This can help Phyto Riker to build a more holistic ecosystem as suggested in the Phyto-Riker Pharmaceuticals case study. Phyto Riker can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.

Harnessing reconfiguration of the global supply chains

– As the trade war between US and China heats up in the coming years, Phyto Riker can build a diversified supply chain model across various countries in - South East Asia, India, and other parts of the world. This reconfiguration of global supply chain can help, as suggested in case study, Phyto-Riker Pharmaceuticals, to buy more products closer to the markets, and it can leverage its size and influence to get better deal from the local markets.

Remote work and new talent hiring opportunities

– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Phyto Riker to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Phyto Riker to hire the very best people irrespective of their geographical location.

Using analytics as competitive advantage

– Phyto Riker has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Phyto-Riker Pharmaceuticals - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Phyto Riker to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.

Manufacturing automation

– Phyto Riker can use the latest technology developments to improve its manufacturing and designing process in Global Business segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.




Threats Phyto-Riker Pharmaceuticals External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats mentioned in the HBR case study Phyto-Riker Pharmaceuticals are -

Regulatory challenges

– Phyto Riker needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Global Business industry regulations.

High level of anxiety and lack of motivation

– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Phyto Riker needs to understand the core reasons impacting the Global Business industry. This will help it in building a better workplace.

Instability in the European markets

– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Phyto Riker will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.

Stagnating economy with rate increase

– Phyto Riker can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.

Aging population

– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.

Increasing international competition and downward pressure on margins

– Apart from technology driven competitive advantage dilution, Phyto Riker can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate prominent markets illustrated in HBR case study Phyto-Riker Pharmaceuticals .

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Phyto Riker.

Environmental challenges

– Phyto Riker needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Phyto Riker can take advantage of this fund but it will also bring new competitors in the Global Business industry.

Increasing wage structure of Phyto Riker

– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Phyto Riker.

Technology acceleration in Forth Industrial Revolution

– Phyto Riker has witnessed rapid integration of technology during Covid-19 in the Global Business industry. As one of the leading players in the industry, Phyto Riker needs to keep up with the evolution of technology in the Global Business sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Trade war between China and United States

– The trade war between two of the biggest economies can hugely impact the opportunities for Phyto Riker in the Global Business industry. The Global Business industry is already at various protected from local competition in China, with the rise of trade war the protection levels may go up. This presents a clear threat of current business model in Chinese market.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Phyto Riker with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.




Weighted SWOT Analysis of Phyto-Riker Pharmaceuticals Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Phyto-Riker Pharmaceuticals needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of the case study Phyto-Riker Pharmaceuticals is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of the Harvard case study Phyto-Riker Pharmaceuticals is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of Phyto-Riker Pharmaceuticals is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Phyto Riker needs to make to build a sustainable competitive advantage.



--- ---

Andersen Consulting - EMEAI: Reorganization for Revitalization SWOT Analysis / TOWS Matrix

Ashish Nanda, Michael Y. Yoshino , Organizational Development


Tottenham Hotspur plc SWOT Analysis / TOWS Matrix

Joshua D Coval, Lauren H. Cohen, Christopher Malloy , Finance & Accounting


Hill & Knowlton: Knowledge Management SWOT Analysis / TOWS Matrix

Darren Meister, Ken Mark , Technology & Operations


Fred Khosravi and AccessClosure SWOT Analysis / TOWS Matrix

Liz Kind, Richard G. Hamermesh , Innovation & Entrepreneurship


Dairy Farm Group: Redesign of Business Systems and Processes SWOT Analysis / TOWS Matrix

Ali F. Farhoomand, Pauline Ng, Eugenia Ng, Probir Banerjee , Technology & Operations


Amarnath Gupta and Sons: The Family Business SWOT Analysis / TOWS Matrix

Rajesh Panda, Pooja Gupta, Madhvi Sethi , Leadership & Managing People


Kmart and ESL Investments (B): The Sears Merger SWOT Analysis / TOWS Matrix

Stuart C. Gilson, Sarah L. Abbott , Finance & Accounting